Amphiphysin I and II are nerve terminal-enriched proteins containing SH3 do
mains that interact with dynamin and synaptojanin. The amphiphysins may fun
ction in synaptic vesicle endocytosis by targeting synaptojanin and dynamin
to emerging endocytic buds through SH3 domain-independent interactions wit
h clathrin and AP2, We have recently identified and cloned several amphiphy
sin II splice variants that differentially incorporate clathrin-binding dom
ains. To determine whether these domains function in membrane targeting, we
used immunofluorescence to examine the potential localization of amphiphys
in II variants to clathrin-coated pits on plasma membranes purified from tr
ansfected COS-7 cells. Full-length amphiphysin II targets to the plasma mem
brane where it partially co-localizes with clathrin. However, splice varian
ts and deletion constructs lacking clathrin-binding domains still target to
the plasma membrane, and removal of clathrin from the membrane does not af
fect amphiphysin II distribution. Surprisingly, plasma membrane targeting w
as dependent on the presence of a 31-amino acid alternatively spliced seque
nce at the N terminus of amphiphysin II, a result confirmed using subcellul
ar fractionation, In binding assays, the 31-amino acid sequence was also fo
und to facilitate amphiphysin dimerization mediated through the N terminus,
Taken together, these data support a role for the N terminus of amphiphysi
n II in membrane targeting during endocytosis.